BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baluch A, Humar A, Egli A, Gubbay J, Lisboa L, Wilson L, Kumar D. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS One 2011;6:e28627. [PMID: 22194870 DOI: 10.1371/journal.pone.0028627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kotton CN. Optimizing the immunogenicity of pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Expert Review of Vaccines 2014;11:423-6. [DOI: 10.1586/erv.12.19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Egli A, Humar A, Widmer LA, Lisboa LF, Santer DM, Mueller T, Stelling J, Baluch A, O'shea D, Houghton M, Kumar D. Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination. Journal of Infectious Diseases 2015;212:137-46. [DOI: 10.1093/infdis/jiv015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
3 Ison MG. Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Viruses 2013;7 Suppl 1:7-13. [PMID: 23279892 DOI: 10.1111/irv.12046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
4 Felldin M, Andersson B, Studahl M, Svennerholm B, Friman V. Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients. Transpl Int 2014;27:197-203. [DOI: 10.1111/tri.12237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kang EK, Eun BW, Kim NH, Lim JS, Lee JA, Kim DH. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study. BMC Infect Dis 2016;16:438. [PMID: 27549626 DOI: 10.1186/s12879-016-1769-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, Caniza MA, Hertz T, Devincenzo JP, Webby RJ, Thomas PG. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med 2014;189:449-62. [PMID: 24308446 DOI: 10.1164/rccm.201309-1616OC] [Cited by in Crossref: 108] [Cited by in F6Publishing: 80] [Article Influence: 13.5] [Reference Citation Analysis]
7 Duni A, Markopoulos GS, Mallioras I, Pappas H, Pappas E, Koutlas V, Tzalavra E, Baxevanos G, Priska S, Gartzonika K, Mitsis M, Dounousi E. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients. Front Immunol 2021;12:760249. [PMID: 34925330 DOI: 10.3389/fimmu.2021.760249] [Reference Citation Analysis]
8 Oshansky CM, Thomas PG. The human side of influenza. J Leukoc Biol 2012;92:83-96. [PMID: 22362872 DOI: 10.1189/jlb.1011506] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
9 Hirzel C, Ferreira VH, L'Huillier AG, Hoschler K, Cordero E, Limaye AP, Englund JA, Reid G, Humar A, Kumar D; Influenza in Transplant Study Group. Humoral response to natural influenza infection in solid organ transplant recipients. Am J Transplant 2019;19:2318-28. [PMID: 30748090 DOI: 10.1111/ajt.15296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape P, Thiébaut A, Le Goff J, Autran B, Ribaud P. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. Vaccine 2014;32:585-91. [PMID: 24333120 DOI: 10.1016/j.vaccine.2013.11.073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
11 Klein J, Brito A, Trubin P, Lu P, Wong P, Alpert T, Pena-Hernandez M, Haynes W, Kamath K, Liu F, Vogels C, Fauver J, Lucas C, Oh JE, Mao T, Silva J, Wyllie A, Muenker MC, Casanovas-Massana A, Moore A, Petrone M, Kalinich C, Cruz CD, Farhadian S, Ring A, Shon J, Ko A, Grubaugh N, Goldman-Israelow B, Iwasaki A, Azar M; YALE IMPACT RESEARCH TEAM. Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient. Res Sq 2021:rs. [PMID: 34013255 DOI: 10.21203/rs.3.rs-405958/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses 2013;7 Suppl 3:60-6. [PMID: 24215383 DOI: 10.1111/irv.12170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]